Rapid de-localization of actin leading edge components with BDM treatment
<p>Abstract</p> <p>Background</p> <p>2,3-Butanedione monoxime (BDM) has been widely used as a non-muscle myosin inhibitor to investigate the role of non-muscle myosinII in the process of actin retrograde flow and other actin cytoskeletal processes. Recent reports show t...
Main Authors: | Lechler Terry, Yarrow Justin C, Li Rong, Mitchison Timothy J |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2003-06-01
|
Series: | BMC Cell Biology |
Online Access: | http://www.biomedcentral.com/1471-2121/4/5 |
Similar Items
-
On BDM-Algebras
by: mohd Shahoodh
Published: (2023-03-01) -
Dataset and protocols on the applicability of the BDM mechanism in product evaluation
by: Marcel Lichters, et al.
Published: (2019-08-01) -
Spatio-temporal data model for biodiversity data (STOP-BDM)
by: Wahid, Mohd. Taib, et al.
Published: (2007) -
SAS Macro BDM for Fitting the Dale Regression Model to Bivariate Ordinal Response Data
by: Timothy Hanson, et al.
Published: (2005-01-01) -
Smooth Muscle Myosin Localizes at the Leading Edge and Regulates the Redistribution of Actin-regulatory Proteins during Migration
by: Ruping Wang, et al.
Published: (2022-07-01)